Experts said there should be comprehensive, cost-based price controls covering all oncology therapies, permanent statutory margin caps across distribution channels and full scrutiny of company assistance programmes.

QUOTE · 引述
Experts said there should be comprehensive, cost-based price controls covering all oncology therapies, permanent statuto